Movement Disorders and Its Variants.

Dopaminergic Movement disorders PET Tauopathy

Journal

PET clinics
ISSN: 1879-9809
Titre abrégé: PET Clin
Pays: United States
ID NLM: 101260152

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 30 10 2024
Statut: aheadofprint

Résumé

Since the 2000s, Nuclear Medicine has primarily used SPECT with DaTSCAN and PET with [18F]-FDG to explore movement disorders. Recent advances in PET radiotracers, such as LBT 999 for dopamine transporters and tau tracers like flortaucipir for tauopathies, are enhancing diagnostic precision. Other PET tracers target neuroinflammation, synaptic density, cholinergic function, and adenosine A2A receptors. Novel tools like [18F]-ROStrace help detect oxidative stress in neurodegenerative disorders. These developments promise better patient management, reduced examination times, and improved diagnostic accuracy in the exploration of movement disorders pathologies.

Identifiants

DOI: 10.1016/j.cpet.2024.09.012 PMID: 39477718
pubmed: 39477718
pii: S1556-8598(24)00083-X
doi: 10.1016/j.cpet.2024.09.012
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Anne-Sophie Salabert (AS)

ToNIC, Toulouse NeuroImaging Center, UMR 1214, Université de Toulouse, INSERM, Université Paul-Sabatier, Toulouse, France; Department of Radiopharmacy, University Hospital of Toulouse, Toulouse, France.

Pierre Payoux (P)

ToNIC, Toulouse NeuroImaging Center, UMR 1214, Université de Toulouse, INSERM, Université Paul-Sabatier, Toulouse, France; Department of Nuclear Medicine, University Hospital of Toulouse, Place du Dr Baylac, Toulouse Cedex 31059, France. Electronic address: payoux.p@chu-toulouse.fr.

Classifications MeSH